The Pharma Dilemma: Trust, Pricing, and the New Language of Fairness

In this episode of Hearsay, Lee Carter is joined by partners Keith Yazmir and Katie Cronen to unpack why communicating effectively—especially in industries like pharma—is harder than ever. In a world fueled by mistrust, audiences are no longer asking, “Are you doing good?” but rather, “Are you being fair?” The team explores how fairness, not goodness, is now the key to resonating with audiences, especially when discussing sensitive topics like drug pricing, health equity, and scientific trust. They offer practical strategies for corporate communicators to respond with transparency, empathy, and clarity—avoiding jargon and embracing straight talk in a time where silence speaks louder than words.